This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:51, 7 March 2011 (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: ChEMBL.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:51, 7 March 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers from ChemSpider, CommonChemistry and FDA for the Chem/Drugbox validation project - Updated: ChEMBL.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundFile:PROLAD.svg | |
Clinical data | |
---|---|
Other names | PRO-LAD, 6-propyl- 6-nor- Lysergic acid diethylamide, (6aR,9R)- N,N- diethyl- 7-propyl- 4,6,6a,7,8,9- hexahydroindolo- quinoline- 9- carboxamide |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H29N3O |
Molar mass | 351.50 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
PRO-LAD is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a hallucinogenic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.
PRO-LAD has been sold by some research chemical suppliers but might be considered illegal in some countries due to its structural similarity to LSD.
References
- Hoffman AJ, Nichols DE (1985). "Synthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives". Journal of Medicinal Chemistry. 28 (9): 1252–5. PMID 4032428.
{{cite journal}}
: Unknown parameter|month=
ignored (help)
External links
This hallucinogen-related article is a stub. You can help Misplaced Pages by expanding it. |